Pulmonary embolism risk tool study for ER providers
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests a tool that helps emergency room doctors, nurse practitioners, and physician assistants decide when to order CT scans for possible pulmonary embolism (a blood clot in the lungs). It aims to make those decisions safer and more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a doctor, nurse practitioner, or physician assistant working in an emergency department.
- You work at one of these study sites: Northwell Health, Baylor College of Medicine, or NYU Langone Health.
- You order CT scans for adult patients who might have a pulmonary embolism.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a bedside ultrasound done in the emergency room can help predict which people with an acute pulmonary embolism are more likely to have bad outcomes. If you qualify, your care team will compare ultrasound findings with your later results to see if it can guide treatment decisions sooner.
This trial studies a clot-removal device used through a catheter to treat acute pulmonary embolism (a blood clot in the lungs). It aims to see if the device can safely remove clots and improve outcomes compared with standard care planning.
This study looks at how doctors decide to test for pulmonary embolism (a blood clot in the lungs) in the emergency department. It helps understand what factors lead to testing, which could improve care for future patients.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.